Menu

Search Results for "covid-19"

Ivermectin for COVID-19: real-time meta analysis of 65 studies

Ivermectin is an effective treatment for COVID-19. Treatment is more effective when used early. Meta analysis using the most serious outcome reported shows 66% [53‑76%] and 86% [75‑92%] improvement for early treatment and prophylaxis, with similar results after exclusion based sensitivity analysis and restriction to peer-reviewed studies or Randomized Controlled Trials.

Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests

The COVID-19 pandemic caused increased mortality in nursing homes due to its quick spread and the age-related high lethality.

Doxycycline and Hydroxychloroquine as Treatment for High-Risk COVID-19 Patients: Experience from Case Series of 54 Patients in Long-Term Care Facilities

The clinical experience of this case series indicates DOXY-HCQ treatment in high-risk COVID-19 patients is associated with a reduction in clinical recovery, decreased transfer to hospital, and decreased mortality were observed after treatment with DOXY-HCQ.

COVID-19 mortality risk factors in older people in a long-term care center

Male gender, low Barthel index, and lymphocytopenia are independent risk factors for COVID-19 mortality in institutionalized older patients in long-term care nursing homes. Treatment with hydroxychloroquine and azithromycin was associated with lower mortality in these patients.

Effectiveness of a On-site Medicalization Program for Nursing Homes With COVID-19 Outbreaks

A coordinated on-site MP of nursing homes with COVID-19 outbreaks achieved a higher SOPC rate, and a reduction in referrals to hospital, thus ensuring rigorous but also humanistic and gentle care to residents.

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2 and reported to be efficient in Chinese COV-19 patients. We evaluate the effect of hydroxychloroquine on respiratory viral loads.

Assessment of COVID-19 Treatment containing both Hydroxychloroquine and Azithromycin: A natural clinical trial

This natural trial showed that the COVID-19 regimen containing both HCQ and azithromycin can be helpful to promote the recovery of most patients and reduced their signs and symptoms significantly.

Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping Review

Evidence is not sufficiently strong to either promote or refute the efficacy of IVM, DOXY, or their combination in COVID-19 management.

Ivermectin: an award-winning drug with expected antiviral activity against COVID-19

Ivermectin is an FDA-approved antiparasitic agent, being currently investigated in COVID-19 patients.

A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness

The authors declare that there are no known competing financial interests or personal relationships that could have appeared to influence the work described in this paper.

Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19

After COVID-19 emerged on U.S shores, providers began reviewing the emerging basic science, translational, and clinical data to identify potentially effective treatment options. In addition, a multitude of both novel and repurposed therapeutic agents were used empirically and studied within clinical trials.

L’épidémie de COVID-19 déclenchée par un patient entièrement vacciné remet en question la théorie de l’immunité collective induite par le vaccin.

Un article publié le 30 septembre dans Eurosurveillance a montré que la COVID-19 s’est rapidement propagée d’un patient entièrement vacciné à des membres du personnel, des patients et des membres de la famille entièrement vaccinés, malgré un taux de vaccination de 96 % et l’utilisation d’un équipement de protection individuelle complet. Cinq patients sont morts et neuf ont été des cas graves.

Plus de 7 800 médecins et scientifiques accusent les décideurs en charge de la gestion de la crise COVID-19 de « crimes contre l’humanité. »

La déclaration des médecins, élaborée par des médecins et des scientifiques lors du sommet COVID de Rome, accuse les décideurs politiques d’imposer une stratégie de traitement « unique », entraînant « des maladies et des décès inutiles. »

« Les Cassandres » avaient raison : Le « remède » contre la COVID-19 – efficace mondialement à 99 % – s’est avéré bien pire que la maladie

Au début de 2020, des citoyens et des spécialistes des sciences sociales choqués, ont prédit que l’obligation généralisée d’ « interventions non pharmaceutiques » extrêmes en réponse à la COVID-19, conduirait à des contreparties humaines et économiques, horribles et coûteuses, or, il s’avère qu’ils avaient raison.

Le CDC soutient l’approbation par la FDA du vaccin Pfizer contre la COVID-19 chez les personnes de 16 ans et plus, malgré les interrogations sur les données manquantes et sur le vaccin réellement homologué.

Les Centers for Disease Control and Prevention ( CDC – Centres pour le contrôle et la prévention des maladies ) ont déclaré lundi qu’ils approuvaient la « recommandation concernant l’utilisation du vaccin homologué Pfizer-BioNTech pour les personnes de 16 ans et plus » formulée par leur comité consultatif, malgré les déclarations de la Food and Drug Administration (FDA) des États-Unis selon lesquelles le vaccin Pfizer-BioNTech n’a toujours obtenu qu’une AMM (autorisation de mise sur le marché) conditionnelle.

Un outil de contrôle : Comment les responsables de la santé utilisent-ils le langage pour gérer la perception du public à l’égard des vaccins contre la COVID-19?

Le déploiement de ruses linguistiques astucieuses a créé un univers à l’envers hostile, où même les vaccinés ayant subit des effets indésirables sont désignés comme des « anti-vax » ou des menteurs plutôt que reconnus comme des ex-vax ayant pris des risques qui se sont révélés être boulversants pour leur vie.

Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial

We examined whether existing licensed pharmacotherapies could reduce the spread of coronavirus disease 2019 (COVID-19).

Increased risk for Covid-19 in patients with Vitamin D deficiency.

Vit D deficiency increased likelihood of being COVID-19 positive by 4.6 times.

Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study.

Hospitalized COVID-19 patients with diabetes had a 85.7% lower death rate when given Vit D.

Nutrients, Low 25-Hydroxyvitamin D Levels on Admission to the Intensive Care Unit May Predispose COVID-19 Pneumonia Patients to a Higher 28-Day Mortality Risk: A Pilot Study on a Greek ICU Cohort.

Observational study showing improved immune system activity if supplementation was given to Vit D insufficient and deficient patients.

Nutrients, High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study.

An 80% decrease in death among hospitalized (late treatment) patients in the UK given Vitamin D.

Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests.

Italian nursing home patients given Vitamin D before being exposed to COIVD 19 had a 70% decrease in death.

Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19).

Early treatment of COVID-19 with sequential multidrug treatment (SMDT) that has been shown to be safe and effective for non-hospitalized patients with symptoms of COVID 19.

Vitamin D Status is Associated With In-hospital Mortality and Mechanical Ventilation: A Cohort of COVID-19 Hospitalized Patients

Patients with higher Vitamin D levels had significantly lower death rate.

Est ce que le vaccin antigrippal augmente le risque de contracter la COVID-19 ?

De nombreuses études établissent un lien entre la vaccination contre la grippe et un risque accru de la COVID. Une analyse a révélé que dans les pays européens où les taux de mortalité dûs à la COVID-19 étaient les plus élevés, avaient vaccinés plus de 50 % des personnes âgées contre la grippe.

Comment saurons-nous qu’un vaccin COVID-19 est sans danger?

Dans une vidéo produite par Children’s Health Defense, la Dre. Mumper passe en revue les nombreuses préoccupations de la communauté scientifique au sujet de la sécurité d’un vaccin COVID et de ses ingrédients, et fournit des informations sur chacun des principaux candidats vaccins COVID.

La loi de Gresham et la pandémie de Covid-19

Si la mauvaise science, telle la mauvaise monnaie, prend le contrôle du monde, la loi de Gresham s’appliquera à la pharmacologie et seuls les médicaments coûteux auront des résultats positifs.

Commentary: Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease

The risk antibody‐dependent enhancement (ADE) during COVID-19 vaccine trials was sufficiently obscured in clinical trial protocols and consent forms that adequate patient comprehension of this risk is unlikely to occur, obviating truly informed consent by subjects in these trials.

Prospects for a safe COVID-19 vaccine

Although animal models of SARS-CoV-2 infection may elucidate mechanisms of immune protection, we need observations of enhanced disease in people receiving candidate COVID-19 vaccines to understand the risk of immune enhancement of disease. Neither principles of immunity nor preclinical studies provide a basis for prioritizing among the COVID-19 vaccine candidates with respect to safety at this time.

Positive association between COVID-19 deaths and influenza vaccination rates in elderly people worldwide

There is a positive association between COVID-19 deaths and Influenza Vaccination Rate (IVR) of people ≥65 years-old.